Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $13.12 billion. The enterprise value is $12.45 billion.
| Market Cap | 13.12B |
| Enterprise Value | 12.45B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 251.36 million shares outstanding. The number of shares has decreased by -6.54% in one year.
| Current Share Class | 251.36M |
| Shares Outstanding | 251.36M |
| Shares Change (YoY) | -6.54% |
| Shares Change (QoQ) | -2.86% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 89.55% |
| Float | 204.46M |
Valuation Ratios
The trailing PE ratio is 16.39 and the forward PE ratio is 14.76. Exelixis's PEG ratio is 1.40.
| PE Ratio | 16.39 |
| Forward PE | 14.76 |
| PS Ratio | 5.39 |
| Forward PS | 4.76 |
| PB Ratio | 7.05 |
| P/TBV Ratio | 7.37 |
| P/FCF Ratio | 11.19 |
| P/OCF Ratio | 11.09 |
| PEG Ratio | 1.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.45, with an EV/FCF ratio of 10.62.
| EV / Earnings | 14.46 |
| EV / Sales | 5.11 |
| EV / EBITDA | 12.45 |
| EV / EBIT | 12.81 |
| EV / FCF | 10.62 |
Financial Position
The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.46 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 44.39% and return on invested capital (ROIC) is 66.00%.
| Return on Equity (ROE) | 44.39% |
| Return on Assets (ROA) | 23.97% |
| Return on Invested Capital (ROIC) | 66.00% |
| Return on Capital Employed (ROCE) | 45.56% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | $2.26M |
| Profits Per Employee | $799,093 |
| Employee Count | 1,077 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 3.28 |
Taxes
In the past 12 months, Exelixis has paid $174.84 million in taxes.
| Income Tax | 174.84M |
| Effective Tax Rate | 16.89% |
Stock Price Statistics
The stock price has increased by +39.35% in the last 52 weeks. The beta is 0.42, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +39.35% |
| 50-Day Moving Average | 53.97 |
| 200-Day Moving Average | 46.10 |
| Relative Strength Index (RSI) | 41.18 |
| Average Volume (20 Days) | 2,600,954 |
Short Selling Information
The latest short interest is 30.91 million, so 12.30% of the outstanding shares have been sold short.
| Short Interest | 30.91M |
| Short Previous Month | 28.54M |
| Short % of Shares Out | 12.30% |
| Short % of Float | 15.12% |
| Short Ratio (days to cover) | 10.75 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.44 billion and earned $860.62 million in profits. Earnings per share was $3.19.
| Revenue | 2.44B |
| Gross Profit | 2.35B |
| Operating Income | 992.02M |
| Pretax Income | 1.04B |
| Net Income | 860.62M |
| EBITDA | 999.81M |
| EBIT | 971.51M |
| Earnings Per Share (EPS) | $3.19 |
Balance Sheet
The company has $839.39 million in cash and $165.93 million in debt, with a net cash position of $673.46 million or $2.68 per share.
| Cash & Cash Equivalents | 839.39M |
| Total Debt | 165.93M |
| Net Cash | 673.46M |
| Net Cash Per Share | $2.68 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 7.41 |
| Working Capital | 888.90M |
Cash Flow
In the last 12 months, operating cash flow was $1.18 billion and capital expenditures -$10.96 million, giving a free cash flow of $1.17 billion.
| Operating Cash Flow | 1.18B |
| Capital Expenditures | -10.96M |
| Depreciation & Amortization | 28.30M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.17B |
| FCF Per Share | $4.66 |
Margins
Gross margin is 96.48%, with operating and profit margins of 40.72% and 35.33%.
| Gross Margin | 96.48% |
| Operating Margin | 40.72% |
| Pretax Margin | 42.51% |
| Profit Margin | 35.33% |
| EBITDA Margin | 41.04% |
| EBIT Margin | 39.88% |
| FCF Margin | 48.13% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.54% |
| Shareholder Yield | 6.54% |
| Earnings Yield | 6.56% |
| FCF Yield | 8.94% |
Analyst Forecast
The average price target for Exelixis is $52.88, which is 1.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $52.88 |
| Price Target Difference | 1.30% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | 11.62% |
| EPS Growth Forecast (3Y) | 15.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |